|
Sign In to gain access to subscriptions and/or personal tools.
|
Adenoviral-mediated Gene Transfer to Mouse Salivary Glands
S. Wang
Gene Therapy and Therapeutics Branch
B.J. Baum
Gene Therapy and Therapeutics Branch
S. Yamano
Gene Therapy and Therapeutics Branch
M.H. Mankani
Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bldg. 10, 1N113, MSC-1190, Bethesda, MD 20892-1190
D. Sun
Gene Therapy and Therapeutics Branch
M. Jonsson
Gene Therapy and Therapeutics Branch
C. Davis
Gene Therapy and Therapeutics Branch
F.L. Graham
Dept. of Biology, Dept of Pathology, Health Sciences Centre, McMaster University, Hamilton, Ontario, Canada
J. Gauldie
Dept of Pathology, Health Sciences Centre, McMaster University, Hamilton, Ontario, Canada
J.C. Atkinson
Gene Therapy and Therapeutics Branch, Corresponding author, jatkinson{at}dir.nidcr.nih.gov
Adenoviral vectors effectively transfer genes to rat salivary glands. However, potent immune responses limit their use in vivo. Mice offer more opportunities than rats for the study of these immune processes. We first established conditions for infection of mouse salivary glands, with an adenoviral vector. The effects of time, viral dose, viral diluent buffer volume, and dexamethasone on expression of a transgene, luciferase, were determined by means of the recombinant vector AdCMVluc. Optimal luciferase expression was observed when the vector was suspended in 50 µL of buffer. This volume completely filled the gland parenchyma and slightly distended the capsule. Dexamethasone increased immediate transgene expression and reduced the acute inflammation one day following viral administration, but did not alter subsequent mononuclear inflammation or transgene expression 14 or 28 days later. An adenoviral vector encoding either antiinflammatory cytokine IL-4 or IL-10 was co-administered with AdCMVluc to increase transgene expression at 14 and 28 days. While this strategy did not extend the duration of luciferase expression, co-administration of AdCMVIL-10 with AdCMVluc almost completely eliminated the chronic inflammatory infiltrate in the glands after 28 days. This study demonstrates that adenoviral-mediated gene transfer to mouse submandibular glands is possible by intraductal cannulation and that reduction of either the acute or chronic inflammatory infiltrates was insufficient to increase long-term transgene expression in this tissue.
Key Words: Salivary glands gene transfer gene therapy.
REFERENCES
- Addison CA, Gauldie J., Muller WJ, Graham FL (1995). An adenovirus vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model. Int J Oncol 7:1253-1260.
- Adesanya MR, Redman RS, Baum BJ, O'Connell BC (1996). Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum Gene Ther 7:1085-1093.[Medline]
[Order article via Infotrieve]
- Baum BJ, O'Connell BC (1999). In vivo gene transfer to salivary glands. Crit Rev Oral Biol Med 10:276-283.[Abstract/Free Full Text]
- Bromberg JS, Debruyne LA, Qin L. (1998). Interactions between the immune system and gene therapy vectors: bidirectional regulation of response and expression. Adv Immunol 69:353-409.[Medline]
[Order article via Infotrieve]
- Cook DI, Van Lennep EW, Roberts M., Young JA (1994). Secretion by the major salivary glands. In: Physiology of the gastrointestinal tract. Johnson LR, editor. New York: Raven, pp. 1061-1117.
- David A., Coupel-Clauce H., Chetritt J., Tesson L., Cassard A., Charreau B., et al. (1998). Anti-adenovirus immune responses in rats are enhanced by interleukin 4 but not interleukin 10 produced by recombinant adenovirus. Hum Gene Ther 9:1755-1768.[Medline]
[Order article via Infotrieve]
- Delporte C., O'Connell BC, He X., Lancaster HE, O'Connell AC, Agre P., et al. (1997a). Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA 94:3268-3273.[Abstract/Free Full Text]
- Delporte C., Redman RS, Baum BJ ( 1997b). Relationship between the cellular distribution of the
vβ3/5 integrins and adenoviral infection in salivary glands. Lab Invest 77:167-173.[Medline]
[Order article via Infotrieve] - Gilgenkrantz H., Duboc D., Juillard V., Couton D., Pavirani A., Guillet JG, et al. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther 6:1265-1274.[Medline]
[Order article via Infotrieve]
- Graham FL, Prevec L. (1991). Manipulation of adenovirus vectors. In: Methods in molecular biology. Vol. 7. Gene transfer and expression techniques. Murray EJ, Walker JM, editors. Clifton, NJ: Humana Press Inc., pp. 109-128.
- He X., Goldsmith CM, Marmary Y., Wellner RB, Parlow AF, Nieman LK, et al. (1998). Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther 5:537-541.[CrossRef][Medline]
[Order article via Infotrieve]
- Hitt M., Bett AJ, Addison C., Prevec L., Graham FL (1995). Techniques for human adenovirus vector construction and characterization. In: Methods in molecular genetics. Vol. 7B. Adolph KW, editor. Orlando: Academic Press, pp. 13-30.
- Hitt M., Addison C., Graham FL (1997). Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 40:137-206.[Medline]
[Order article via Infotrieve]
- Hood LE, Weissman IL, Wood WB, Wilson JH (1984). Immunology. 2nd rev. ed. Menlo Park, CA: Benjamin/ Cummings.
- Ilan Y., Prakash R., Davidson A., Jona V., Droguett G., Horwitz MS, et al. (1997). Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest 99:1098-1106.[Medline]
[Order article via Infotrieve]
- Kagami H., O'Connell BC, Baum BJ ( 1996). Evidence for the systemic delivery of a transgene product from salivary glands. Hum Gene Ther 7:2177-2184.[Medline]
[Order article via Infotrieve]
- Kagami H., Atkinson JC, Michalek SM, Handelman B., Yu S., Baum BJ, et al. (1998). Repetitive adenovirus administration to parotid gland: role of immunological barriers and induction of oral tolerance. Hum Gene Ther 9:305-313.[Medline]
[Order article via Infotrieve]
- Mastrangeli A., O'Connell B., Aladib W., Fox PC, Baum BJ, Crystal RG (1994). Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 266:G1146-G1155.
- Moore KW, O'Garra A., de Waal Malefyt R., Vieira P., Mosmann TR (1993). Interleukin-10. Ann Rev Immunol 11:163-190.
- Mosmann TR (1994). Properties and functions of interleukin-10. Adv Immunol 56:1-26.[Medline]
[Order article via Infotrieve]
- O'Connell BC, Xu T., Walsh TJ, Sein T., Mastrangeli A., Crystal RG, et al. (1996). Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum Gene Ther 7:2255-2261.[Medline]
[Order article via Infotrieve]
- Rocken M., Racke M., Shevach EM (1996). IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231.[CrossRef][Medline]
[Order article via Infotrieve]
- Verma IM, Somia N. (1997). Gene therapy-promises, problems and prospects [news]. Nature 389:239-242.[CrossRef][Medline]
[Order article via Infotrieve]
- Wang SL, Baum BJ, Kagami H., Zheng C., O'Connell BC, Atkinson JC (1999). Effect of clodronate on macrophage depletion and adenoviral-mediated transgene expression in salivary glands. J Oral Pathol Med 28:145-151.[Medline]
[Order article via Infotrieve]
- Wilson JM (1996). Adenoviruses as gene-delivery vehicles. N Engl J Med 334:1185-1187.[Free Full Text]
- Worgall S., Wolff G., Falck-Pedersen E., Crystal RG (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8:37-44.[Medline]
[Order article via Infotrieve]
- Xing Z., Ohkawara Y., Jordana M., Graham FL, Gauldie J. (1997). Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther 4:140-149.[CrossRef][Medline]
[Order article via Infotrieve]
- Yang Y., Ertl HC, Wilson JM (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433-442.[CrossRef][Medline]
[Order article via Infotrieve]
- Yang Y., Li Q., Ertl HC, Wilson JM (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015.[Abstract]
- Yang Y., Greenough K., Wilson JM (1996). Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther 3:412-420.[Medline]
[Order article via Infotrieve]
Journal of Dental Research, Vol. 79, No. 2,
701-708 (2000)
DOI: 10.1177/00220345000790020201

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. K. Parvadia, S. G. Keswani, S. Vaikunth, A. R. Maldonado, A. Marwan, W. Stehr, C. Erwin, E. Uzvolgyi, B. W. Warner, S. Yamano, et al.
Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent
Am J Physiol Gastrointest Liver Physiol,
September 1, 2007;
293(3):
G591 - G598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. PIHLSTROM and L. TABAK
The National Institute of Dental and Craniofacial Research: Research for the practicing dentist
J Am Dent Assoc,
June 1, 2005;
136(6):
728 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. BAUM, M. KOK, S. D. TRAN, and S. YAMANO
The impact of gene therapy on dentistry: A revisiting after six years
J Am Dent Assoc,
January 1, 2002;
133(1):
35 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.J. Baum
Prospects for Re-engineering Salivary Glands
Advances in Dental Research,
December 1, 2000;
14(1):
84 - 88.
[Abstract]
[PDF]
|
 |
|
|
|